EUVIMEDEUVIMED entdecken
Crossref

Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A

Porkizhi Arjunan, Gokulnath Mahalingam, Priyanka Sankar, Durga Kathirvelu, Sevanthy Suresh, Sandya Rani, Kumarasamypet M Mohankumar, Saravanabhavan Thangavel, Srujan Marepally

Biomaterials Science · 2024 · 12 (19) · 5052-5062

DOI: 10.1039/d4bm00909f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2024. Verfasst von Porkizhi Arjunan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Stem Cell Research (CSCR) (a unit of inStem, Bengaluru), CMC Campus, Vellore, 632002, TN, India. srujankm@cmcvellore.ac.in. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII, Nanoparticles, RNA, Messenger. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Development of a novel therapeutic strategy to treat Haemophilia A, encompassing liver-specific Gal-LNPs mediated delivery and enhanced mRNA translation for effective production of functional Factor VIII with a therapeutically relevant precision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AFactor VIIINanoparticlesRNA, MessengerAnimalsHumansMiceGalactoseLipidsPseudouridineLiverCell LineMaleLiposomes

Substanzen

Factor VIIIRNA, MessengerGalactoseLipidsPseudouridineLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Centre for Stem Cell Research (CSCR) (a unit of inStem, Bengaluru), CMC Campus, Vellore, 632002, TN, India. srujankm@cmcvellore.ac.in.
  • Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.

Förderung

  • Council of Scientific and Industrial Research, India
  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Arjunan, P., Mahalingam, G., Sankar, P., Kathirvelu, D., Suresh, S., Rani, S., Mohankumar, K. M., Thangavel, S., & Marepally, S. (2024). Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A. Biomaterials Science, 12(19), 5052-5062. https://doi.org/10.1039/d4bm00909f

Vancouver

Arjunan P, Mahalingam G, Sankar P, Kathirvelu D, Suresh S, Rani S, et al. Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A. Biomaterials Science. 2024;12(19):5052-5062. doi:10.1039/d4bm00909f

BibTeX
@article{Arjunan2024,
  author = {Arjunan, Porkizhi and Mahalingam, Gokulnath and Sankar, Priyanka and Kathirvelu, Durga and Suresh, Sevanthy and Rani, Sandya and Mohankumar, Kumarasamypet M and Thangavel, Saravanabhavan and Marepally, Srujan},
  title = {Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A},
  journal = {Biomaterials Science},
  year = {2024},
  volume = {12},
  number = {19},
  pages = {5052--5062},
  doi = {10.1039/d4bm00909f}
}
Kostenlos starten →